期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 107, 期 -, 页码 156-162出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2016.09.003
关键词
Blastic plasmacytoid dendritic cell neoplasm; HyperCVAD; Allogeneic hematopoeitic cell transplant; Autologous hematopoeitic cell transplant
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive tumor derived from the precursors of plasmacytoid dendritic cells. It is a rare disease presenting across all ages with either skin or both skin and bone marrow involvement often conferring a poor prognosis. Though localized radiation has been used before, acute leukemia based regimens, remains the treatment of choice for induction of remission. Hematopoietic stem cell transplant, either autologous or allogeneic, is further required for attaining sustained remissions. Recently, a number of targeted therapies and newer drugs have been used as the molecular and genetic understanding of the disease have improved. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据